Gyon Technologies Capital Management, LP Cti Biopharma Corp Transaction History

Gyon Technologies Capital Management, LP

  • $0
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$4.45 - $6.17 $497,914 - $690,367
111,891 Added 138.24%
192,831 $1.16 Million
Q3 2022

Nov 14, 2022
BUY
$5.36 - $7.43 $433,838 - $601,384
80,940 New
80,940 $471,000
Q4 2021

Feb 11, 2022
SELL
$1.44 - $2.86 $194,404 - $386,108
-135,003 Closed
0 $0
Q3 2021

Nov 18, 2021
BUY
$2.25 - $3.18 $303,756 - $429,309
135,003 New
135,003 $398,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email